Research

The Brain Cancer Research Alliance is committed to funding breakthrough research that advances understanding, treatment, and ultimately cures for brain cancer. We invest in cutting-edge studies, early-stage innovation, and collaborative partnerships with leading scientists, hospitals, and research institutions.

We support research focused on understanding the genetic drivers and treatment options for oligodendroglioma — a rare but treatable type of brain tumor.

Astrocytomas vary from low-grade to high-grade forms. We fund studies exploring innovative therapies, surgical advancements, and personalized medicine to improve patient outcomes.

Glioblastoma is one of the most aggressive and complex brain cancers. Our funding helps drive research into targeted therapies, immunotherapies, and clinical trials aimed at extending survival and improving quality of life.

• Immunotherapy
• Predictive Analytics as it applies to radiation and combination therapies
• Brain tumor early detection & diagnosis
• Blood-brain barrier breakthroughs
• Personalized medicine

BCRA works closely with medical experts and research partners to evaluate and fund projects that demonstrate:

• Scientific innovation
   
• Potential for clinical impact
   
• Collaborative, multi-institutional research teams
   
• A focus on improving survival and quality of life for brain cancer patients

We are proud to collaborate with leading hospitals, academic research centers, and dedicated scientists committed to defeating brain cancer.

Some of the institutions we partner with are: 

• University of Florida 
• Dana Farber
• National Brain Tumor Society

Every new discovery brings us one step closer to better treatments, longer survival, and eventually — cures. With your support, we can continue to accelerate progress for patients and families worldwide.